Evidence map›Paper›PMID 12953096›Full record

ArticleThe Journal of experimental medicine2003

Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice.

Jorn Drappa, Lynn A Kamen, Elena Chan, Maria Georgiev, Dalit Ashany, Francesc Marti, Philip D King

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. T Cell-Specific Adaptor Protein Regulates Mitochondrial Function and CD4Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  5. Article
  6. Article
  7. The docking protein FRS2α is a critical regulator of VEGF receptors signaling.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Genetics of SLE in mice.Springer seminars in immunopathology · 2006
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jorn DrappaResearch Division, Hospital for Special Surgery, Weill Medical College and Graduate School of Medical Sciences, Cornell University, New York, NY 10021, USA.
Lynn A Kamen
Elena Chan
Maria Georgiev
Dalit Ashany
Francesc Marti
Philip D King
Cornell University · USHospital for Special Surgery · US

Funding

Control of T cell activation by the TSAd adapter proteinR01AI050699 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, PHILIP D · 2002 to 2006
$1.4M
REGULATION OF CD28 SIGNAL TRNSDUCTIONR01AI044926 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, PHILIP D · 1999 to 2003
$855k
NIAID NIH HHS AI 044926NIAID NIH HHS AI 050699NIAID NIH HHS R01 AI044926NIAID NIH HHS R01 AI050699
6 · The paper itself

Abstract

T cell-specific adaptor protein (TSAd) is a T lineage-restricted signaling adaptor molecule that is thought to participate in the assembly of intracellular signaling complexes in T cells. Previous studies of TSAd-deficient mice have revealed a role for TSAd in the induction of T cell interleukin 2 secretion and proliferation. We now show that TSAd-deficient mice are susceptible to lupus-like autoimmune disease. On the nonautoimmune-prone C57BL/6 genetic background, TSAd deficiency results in hypergammaglobulinemia that affects all immunoglobulin (Ig)G subclasses. Older C57BL/6 TSAd-deficient mice (1 yr of age) accumulate large numbers of activated T and B cells in spleen, produce autoantibodies against a variety of self-targets including single stranded (ss) and double stranded (ds) DNA, and, in addition, develop glomerulonephritis. We further show that immunization of younger C57BL/6 TSAd-deficient mice (at age 2 mo) with pristane, a recognized nonspecific inflammatory trigger of lupus, results in more severe glomerulonephritis compared with C57BL/6 controls and the production of high titer ss and ds DNA antibodies of the IgG subclass that are not normally produced by C57BL/6 mice in this model. The development of autoimmunity in TSAd-deficient mice is associated with defective T cell death in vivo. These findings illustrate the role of TSAd as a critical regulator of T cell death whose absence promotes systemic autoimmunity.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutoimmune DiseasesCarrier ProteinsCD4-Positive T-LymphocytesCell DeathDisease Models, AnimalHypergammaglobulinemiaImmunoglobulin GImmunoglobulin MInterleukin-2Lupus Erythematosus, SystemicLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutAdaptor Proteins, Signal TransducingCarrier ProteinsImmunoglobulin GImmunoglobulin MInterleukin-2SH2D2A protein, human

Identifiers

PMID12953096
PMCPMC2194195
OpenAlexW2134624990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.